Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cells

Neuroblastoma (NB) is the most common extracranial solid tumour in infants. Unfortunately, most children present with advanced disease and have a poor prognosis. In the present study, we evaluated the role of the peroxisome proliferator-activated receptor γ (PPARγ) agonist rosiglitazone (RGZ) in two...

Descripción completa

Detalles Bibliográficos
Autores principales: Cellai, I, Benvenuti, S, Luciani, P, Galli, A, Ceni, E, Simi, L, Baglioni, S, Muratori, M, Ottanelli, B, Serio, M, Thiele, C J, Peri, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360542/
https://www.ncbi.nlm.nih.gov/pubmed/16969347
http://dx.doi.org/10.1038/sj.bjc.6603344